Published: Sat, July 15, 2017
Health Care | By Oscar Goodwin

Simon Dingemans Buys 7 Shares of GlaxoSmithKline plc (GSK) Stock

Shares of GlaxoSmithKline plc (LON:GSK) have been assigned a consensus rating of "Hold" from the twenty-three brokerages that are now covering the firm, reports. Over the last 30 and 90 trading days the company share price has decreased 57.26 points and decreased 18 points respectively.

Other equities analysts have also recently issued research reports about the stock. About 2.37 million shares traded. Roundview Capital LLC raised its stake in shares of GlaxoSmithKline PLC by 157.4% in the first quarter. Wesbanco Bank Inc. now owns 12,765 shares of the pharmaceutical company's stock worth $538,000 after buying an additional 350 shares during the last quarter.

Greylin Investment Mangement Inc increased its stake in Glaxosmithkline Plc (GSK) by 88.57% based on its latest 2016Q4 regulatory filing with the SEC. M&R Capital Management Inc. raised its position in GlaxoSmithKline PLC by 22.5% in the fourth quarter. Creative Planning augmented its position by buying 3,424 shares an increase of 3.3% in the quarter. Finally, Jefferies Group LLC upped their price target on shares of GlaxoSmithKline plc from GBX 1,800 ($23.32) to GBX 1,900 ($24.61) and gave the stock a buy rating in a research report on Thursday, March 9th. Jacobs & Co. CA now owns 82,926 shares of the pharmaceutical company's stock worth $3,575,000 after buying an additional 2,833 shares during the last quarter.

Human remains found amid search for 4 missing men
Weintraub said at a news conference on Wednesday, "I feel that we bought ourselves a little bit of time in charging Mr. Officials say Meo is known to be a diabetic, and during the search of his vehicle his "diabetic kit" was found.

The P/E ratio is 47.88 and market capitalization is 103.88B. The stock has a 50 day moving average price of $43.56 and a 200 day moving average price of $41.27. The 1 year high share price is 1745.56 GBX while the 52 week low for the stock is 1446.5 GBX. GlaxoSmithKline PLC had a net margin of 5.48% and a return on equity of 113.31%. The business had revenue of $9.23 billion during the quarter, compared to analysts' expectations of $9.09 billion.

The firm also recently announced a dividend, which was paid on Thursday, July 13th. Llc has 0.45% invested in the company for 229,491 shares. This is an increase from GlaxoSmithKline PLC's previous quarterly dividend of $0.46. This represents a yield of 1.21%. The ex-dividend date of this dividend was Thursday, May 11th. GlaxoSmithKline PLC's dividend payout ratio is 233.74%.

WARNING: This piece was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of United States and worldwide copyright and trademark laws. The original version of this news story can be viewed at

Himachal Govt. orders CBI probe of gang-rape of minor girl
The Shimla Press Club took out a candle march to protest against the incident and demanded the immediate arrest of the culprits. The difference in the details given out over two days perpetuated a doubt that the police had shielded some people.

Several brokerages have issued reports on GSK. Anchor Capital Advisors Llc acquired 9,875 shares as Glaxosmithkline Plc (GSK)'s stock rose 5.47%. Jefferies upgraded GlaxoSmithKline plc (ADR) (NYSE:GSK) on Thursday, July 14 to "Buy" rating. Argus Research maintained the shares of GSK in report on Friday, August 12 with "Buy" rating. The firm has "Neutral" rating by J P Morgan Chase Co given on Friday, June 16. The rating was upgraded by Bank of America to "Neutral" on Tuesday, September 8. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the stock. The firm earned "Hold" rating on Wednesday, February 22 by Berenberg.

About GlaxoSmithKline plc GlaxoSmithKline plc is a global healthcare company. The Firm operates through three divisions: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

GlaxoSmithKline PLC (NYSE:GSK) last posted its quarterly earnings data on Wednesday, April 26th.

Venus Williams on verge of history in Wimbledon final vs. Garbine Muguruza
It's just - yeah, I mean, I'm just ..." a visibly shaken Williams said, before breaking down and walking out of the room. On losing to one Williams and then beating another, Muguruza said: "Two years ago I lost in the final here to Serena".

Like this: